JPH06246150A - Production of liposome - Google Patents
Production of liposomeInfo
- Publication number
- JPH06246150A JPH06246150A JP6094593A JP6094593A JPH06246150A JP H06246150 A JPH06246150 A JP H06246150A JP 6094593 A JP6094593 A JP 6094593A JP 6094593 A JP6094593 A JP 6094593A JP H06246150 A JPH06246150 A JP H06246150A
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- porous material
- membrane
- liposome
- dried
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、リポソームの製造方法
に関する。FIELD OF THE INVENTION The present invention relates to a method for producing liposomes.
【0002】[0002]
【従来の技術】脂質の閉鎖小胞体であるリポソームは、
生体膜モデルとして、また内部に親油性物質、親水性物
質を保持することが可能であるためドラッグキャリヤー
やセンサーなどへの応用が検討されている。2. Description of the Related Art Liposomes, which are closed vesicles of lipids,
As a biomembrane model, it is possible to retain lipophilic substances and hydrophilic substances inside, and its application to drug carriers and sensors is being studied.
【0003】リポソームの代表的な製造法であるボルテ
クスィング法は、ガラス表面に膜構成脂質の薄膜を形成
させた後、水溶液を加えて薄膜を膨潤水和させ、さらに
機械的振動を与える方法(Methods Member.Biol.,1,1(1
974))である。The vortexing method, which is a typical method for producing liposomes, is a method in which a thin film of the lipid constituting the membrane is formed on the glass surface, and then an aqueous solution is added to swell and hydrate the thin film, and mechanical vibration is applied ( Methods Member.Biol., 1,1 (1
974)).
【0004】[0004]
【発明が解決しようとする課題】しかし、この方法は実
験室的には非常に有効であるが、均一な粒径が得られ
ず、また、工業的な大量生産には適していない。However, although this method is very effective in the laboratory, it cannot obtain a uniform particle size and is not suitable for industrial mass production.
【0005】本発明の目的は、大量、かつ均一な粒径を
有するリポソームの製造方法を提供することにある。An object of the present invention is to provide a method for producing a large amount of liposomes having a uniform particle size.
【0006】[0006]
【課題を解決するための手段】そこで、本発明者らは、
前記課題を解決するため鋭意研究を重ねた結果、多孔性
材質に膜構成脂質を付着させ、次いで多孔性材質の表面
と水溶液とを接触させれば、前記課題が解決できるとの
知見を得て本発明を完成した。Therefore, the present inventors have
As a result of repeated intensive studies to solve the above problems, it was found that the above problems can be solved by attaching the membrane-constituting lipid to the porous material and then contacting the surface of the porous material with the aqueous solution. The present invention has been completed.
【0007】多孔性材質としては、例えば、金属、ガラ
ス、セラミックなどの多孔性焼結体などを使用すること
ができる。多孔性材質の孔径または空隙は、0.15〜
1000μm、特に10〜100μmが適している。ま
た、多孔性材質の厚みは、膜構成脂質の保持率と圧力を
考慮すると5〜100mmが適している。As the porous material, for example, a porous sintered body such as metal, glass or ceramic can be used. The pore diameter or void of the porous material is 0.15
1000 μm, especially 10 to 100 μm are suitable. In addition, the thickness of the porous material is preferably 5 to 100 mm in consideration of the retention rate of the lipid constituting the membrane and the pressure.
【0008】膜構成脂質としては、卵黄レシチン、大豆
レシチン、フォスファチジルコリン、フォスファチジル
エタノールアミン、フォスファチジルセリン、フォスフ
ァチジルイノシトール、スフィンゴミエリンなどのリン
脂質、ショ糖脂肪酸エステル、トレハロース脂肪酸エス
テル、ラムノース脂肪酸エステルなどの糖脂肪酸エステ
ルの1種または2種以上、または、これらの混合物を用
いることができる。Membrane constituent lipids include phospholipids such as egg yolk lecithin, soybean lecithin, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol and sphingomyelin, sucrose fatty acid ester, trehalose fatty acid. One or more of sugar fatty acid esters such as ester and rhamnose fatty acid ester, or a mixture thereof can be used.
【0009】膜構成成分としては、この他に膜安定化剤
として、コレステロールなどのステロール類、荷電物質
としてフォスファチジン酸、ジセチルフォスフェート、
ガングリオシド、ステアリルアミンなどが、また、酸化
防止剤として、トコフェロールなどを加えてもよい。In addition to the above, as membrane constituents, sterols such as cholesterol as a membrane stabilizer, phosphatidic acid as a charged substance, dicetyl phosphate,
Ganglioside, stearylamine and the like may be added, and tocopherol and the like may be added as an antioxidant.
【0010】これらの膜構成物質の組成比率は、特に限
定されないが、リン脂質1重量部に対しステロール類0
〜0.5重量部、荷電物質0〜0.1重量部、酸化防止
剤を0〜0.1重量部程度加えるのが好ましい。The composition ratio of these membrane-constituting substances is not particularly limited, but 1 part by weight of phospholipid and 0 of sterols.
˜0.5 parts by weight, 0 to 0.1 parts by weight of the charged substance, and 0 to 0.1 parts by weight of the antioxidant are preferably added.
【0011】水溶液は、多孔性材質を通過させ、その表
面に乾固した膜構成脂質を膨潤、分散させるもので、水
単独、生理食塩水、各種緩衝液、または、糖類を溶解し
た水溶液などを用いることができる。The aqueous solution passes through a porous material, and swells and disperses the dried membrane-constituting lipid on the surface thereof. Water alone, physiological saline, various buffer solutions, or an aqueous solution in which saccharides are dissolved is used. Can be used.
【0012】脂質の閉鎖小胞体であるリポソームは、生
体膜モデルとして、また内部に親油性物質、親水性物質
を保持することが可能で、リポソームに包埋させる物質
として代表的なものに各種薬剤がある。薬剤には親水性
薬剤と親油性薬剤があるが、親水性薬剤の場合には上記
水溶液に溶解し、必要に応じてメタノール、エタノー
ル、アセトン、ジメチルスルホキシド(DMSO)、ジ
オキサンなどの親水性溶剤に溶解して用いる。また、親
油性薬剤の場合には、膜構成脂質に溶解し、必要に応じ
てエタノール、アセトン、クロロホルム、エーテル、ヘ
キサン等の有機溶剤を加えてもよい。Liposomes, which are closed endoplasmic reticulum of lipids, can be used as a biomembrane model and can retain lipophilic substances and hydrophilic substances inside, and are typical as substances to be embedded in liposomes. There is. Drugs include hydrophilic drugs and lipophilic drugs, but in the case of hydrophilic drugs, they are dissolved in the above aqueous solution and, if necessary, added to a hydrophilic solvent such as methanol, ethanol, acetone, dimethylsulfoxide (DMSO) and dioxane. Used by dissolving. Further, in the case of a lipophilic drug, it may be dissolved in the membrane-constituting lipid, and if necessary, an organic solvent such as ethanol, acetone, chloroform, ether or hexane may be added.
【0013】本発明のリポソームの製造は、多孔性材質
を装着した装置に、単独または溶剤に溶解した膜構成脂
質を注入して多孔性材質に十分含浸、付着させ、余分の
脂質は系外に除去する。このとき、必要に応じて多孔性
材質の表面に膜構成脂質をよく付着させるために、膜構
成脂質を数回多孔性材質を通過させる。次いで窒素ガス
などの不活性ガスを通すかまたは真空にして水分や有機
溶剤を除去し、膜構成脂質を乾固させる。そして、十分
に膜構成脂質が乾固した後、水溶液を供給し、乾固した
膜構成脂質と接触(膨潤)させることにより、リポソー
ムの分散した水溶液を得る。この際、ポンプなどで強制
的に繰り返し多孔性材質を通過させたり、超音波やバイ
ブレーターなどで振動を与えることにより膜構成脂質の
水溶液による膨潤の促進および多孔性材質からの膜構成
物質の離脱を促進させ、リポソームを効率的に製造する
ことができる。The liposome of the present invention is produced by injecting a membrane-constituting lipid, alone or dissolved in a solvent, into a device equipped with a porous material so that the porous material is sufficiently impregnated and adhered, and excess lipid is removed from the system. Remove. At this time, the membrane-constituting lipid is passed through the porous material several times in order to adhere the membrane-constituting lipid well to the surface of the porous material, if necessary. Then, an inert gas such as nitrogen gas is passed through or a vacuum is applied to remove water and the organic solvent, and the lipid constituting the membrane is dried. Then, after the membrane-constituting lipid is sufficiently dried, an aqueous solution is supplied and brought into contact (swelling) with the dried membrane-constituting lipid to obtain an aqueous solution in which liposomes are dispersed. At this time, the porous material is forcibly repeatedly passed by a pump or the like, or vibration is applied by an ultrasonic wave or a vibrator to promote swelling of the lipid constituting the membrane by the aqueous solution and release of the membrane constituent from the porous material. It can be promoted to efficiently produce liposomes.
【0014】[0014]
【発明の効果】本発明のリポソーム製造法は、均一なリ
ポソームを大量に製造することができる。INDUSTRIAL APPLICABILITY According to the method for producing liposomes of the present invention, uniform liposomes can be produced in large quantities.
【0015】[0015]
実施例1 20mg/mlの卵黄レシチン、3.8mg/mlのコ
レステロールの膜構成脂質を含有したクロロホルム溶剤
5mlを、直径30mm、厚さ5mmのガラスの焼結体
(孔径40〜100μm)をはさんだ濾過装置に供給
し、多孔性材質中に膜構成脂質を数回通し、十分に多孔
性材質に膜構成脂質を付着させた。次いで室温で窒素ガ
スを吹き込んでクロロホルムを除去し、膜構成脂質を多
孔性材質に乾固した。pH7.4のリン酸緩衝生理食塩
水4mlの一部多孔性材質に付着した膜構成脂質を膨潤
させ、残りのリン酸緩衝生理食塩水を加えてリポソーム
分散液を得た。得られたリポソームの径を粒度分布計
(Nicomp 日油リポソーム(株))で測定した結
果、粒径は平均2.5μm、粒度分布は45%であっ
た。Example 1 5 ml of chloroform solvent containing 20 mg / ml egg yolk lecithin and 3.8 mg / ml cholesterol membrane-constituting lipid was sandwiched with a glass sintered body (pore diameter 40 to 100 μm) having a diameter of 30 mm and a thickness of 5 mm. The membrane-constituting lipid was supplied to the filtration device and passed through the porous material several times to sufficiently attach the membrane-constituting lipid to the porous material. Then, nitrogen gas was blown at room temperature to remove chloroform, and the lipid constituting the membrane was dried on the porous material. 4 ml of phosphate buffered saline having a pH of 7.4 swelled the membrane-constituting lipid attached to the partially porous material, and the remaining phosphate buffered saline was added to obtain a liposome dispersion liquid. The diameter of the obtained liposomes was measured by a particle size distribution meter (Nicomp NOF Liposome Co., Ltd.). As a result, the average particle size was 2.5 μm and the particle size distribution was 45%.
【0016】実施例2 実施例1に準じて、ガラスの焼結体(孔径40〜100
μm)を装着し、20mg/mlの卵黄レシチン、3.
8mg/mlのコレステロールの膜構成脂質を含有した
クロロホルム溶液5mlを供給し、膜構成脂質を実施例
1に準じてガラスの焼結体に付着させた。親水性物質の
サンプルとしてブリリアントブルー0.17mg/ml
を溶解した水溶液1mlで膜構成脂質の付着した多孔性
材質に接触(膨潤)させた後、pH7.4のリン酸緩衝
生理食塩水3mlを加え、さらに超音波をかけてリポソ
ームを得た。得られたリポソームを実施例1に準じて測
定したところ、リポソームの粒径は平均3.0μm、粒
度分布は36%であった。また、リポソーム分散液を限
外濾過して得られた水溶液を分光光度計により標準液と
比較してブリリアントブルーの保持率を測定したところ
15%であった。Example 2 In accordance with Example 1, a glass sintered body (having a pore size of 40 to 100) was prepared.
μm), 20 mg / ml egg yolk lecithin, 3.
5 ml of a chloroform solution containing a membrane-constituting lipid of 8 mg / ml cholesterol was supplied, and the membrane-constituting lipid was adhered to a glass sintered body according to Example 1. Brilliant blue 0.17 mg / ml as a sample of hydrophilic substances
After contacting (swelling) the porous material to which the membrane-constituting lipid was attached with 1 ml of an aqueous solution in which was dissolved, 3 ml of phosphate buffered saline having a pH of 7.4 was added, and ultrasonic waves were further applied to obtain liposomes. When the obtained liposomes were measured according to Example 1, the average particle size of the liposomes was 3.0 μm, and the particle size distribution was 36%. The aqueous solution obtained by ultrafiltration of the liposome dispersion was compared with a standard solution by a spectrophotometer to measure the retention rate of brilliant blue, which was 15%.
【0017】実施例3 ブリリアントブルー0.17mg/mlのエタノール溶
液1mlを実施例1に準じて膜構成脂質のクロロホルム
溶剤5mlに添加した後、ガラスの焼結体に付着、乾固
させた。その後、pH7.4のリン酸緩衝生理食塩水4
mlを加え、さらにバイブレーターで振動をかけてリポ
ソームを得た。得られたリポソームの粒径は実施例1に
準じて測定したところ平均2.0μm、粒度分布は33
%であった。また、リポソーム分散液を限外濾過して得
られた水溶液を分光光度計により標準液と比較してブリ
リアントブルーの保持率を測定したところ63%であっ
た。 この結果、本発明の製造法によるリポソーム化に
より保持率の低い親水性物質であっても保持率が高まる
ことが判明した。Example 3 1 ml of an ethanol solution containing 0.17 mg / ml of brilliant blue was added to 5 ml of a chloroform solvent of a lipid constituting the membrane according to Example 1, and then adhered to a glass sintered body and dried. Then, phosphate buffered saline 4 with pH 7.4
After adding ml, the mixture was vibrated with a vibrator to obtain liposomes. The particle size of the obtained liposomes was measured according to Example 1 to be 2.0 μm on average, and the particle size distribution was 33.
%Met. The aqueous solution obtained by ultrafiltration of the liposome dispersion was compared with a standard solution by a spectrophotometer to measure the retention rate of brilliant blue, which was 63%. As a result, it was found that even if the hydrophilic substance has a low retention rate, the retention rate increases due to the liposome formation by the production method of the present invention.
【0018】実施例4 直径300mm、厚さ7mmの多孔性材質のガラスの焼
結体(孔径40〜100μm)をはさんだ濾過装置に、
20mg/mlの卵黄レシチン、3.8mg/mlのコ
レステロールの膜構成脂質を含有したクロロホルム溶液
500mlを供給し、膜構成脂質を多孔性材質に付着さ
せた。次いで、室温において窒素ガスを吹き込んでクロ
ロホルムを除去し、膜構成脂質を多孔性材質に乾固し
た。pH7.4のリン酸緩衝生理食塩水400mlの一
部で多孔性材質に付着した膜構成脂質を膨張させ、残り
のリン酸緩衝生理食塩水を加えてリポソーム分散液を得
た。得られたリポソームを実施例1に準じて測定したと
ころリポソームの粒径は平均3.0μm、粒度分布は3
6%であった。この結果、本発明の製造法で多孔性材質
の直径と厚さを増せば、容易に処理量を増すことができ
ることが判明した。Example 4 A filtration device sandwiching a sintered glass body (pore diameter 40 to 100 μm) of a porous material having a diameter of 300 mm and a thickness of 7 mm,
500 ml of a chloroform solution containing a membrane-constituting lipid of 20 mg / ml egg yolk lecithin and 3.8 mg / ml cholesterol was supplied, and the membrane-constituting lipid was attached to the porous material. Then, nitrogen gas was blown at room temperature to remove chloroform, and the lipid constituting the membrane was dried on the porous material. The membrane-constituting lipid attached to the porous material was expanded with a part of 400 ml of phosphate buffered saline having a pH of 7.4, and the remaining phosphate buffered saline was added to obtain a liposome dispersion liquid. When the obtained liposomes were measured according to Example 1, the average particle size of the liposomes was 3.0 μm and the particle size distribution was 3
It was 6%. As a result, it was found that the treatment amount could be easily increased by increasing the diameter and thickness of the porous material in the production method of the present invention.
【0019】実施例5 濾過装置に装着した直径300mm、厚さ7mmの多孔
性材質がガラスの焼結体(孔径30〜200μm)であ
る他は、実施例4に準じてリポソーム分散液を作成し
た。リポソームの径を実施例1に準じて測定したとこ
ろ、平均6.0μm、粒度分布は35%であった。ま
た、得られたリポソームをゲル濾過、凍結乾燥し、親油
性の色素であるスダンIIIの保持率を実施例2に準じ
て測定したところ、92%であった。この結果、本発明
の製造法で多孔性材質の直径と厚さを増せば容易に処理
量を増すことができ、また内包する親油性物質の保持率
も高くなることが判明した。Example 5 A liposome dispersion liquid was prepared in the same manner as in Example 4 except that the porous material having a diameter of 300 mm and a thickness of 7 mm mounted on a filtration device was a sintered body of glass (pore diameter 30 to 200 μm). . When the diameter of the liposome was measured according to Example 1, the average was 6.0 μm, and the particle size distribution was 35%. Further, the obtained liposome was subjected to gel filtration and freeze-dried, and the retention rate of the lipophilic dye Sudan III was measured according to Example 2 to be 92%. As a result, it was found that the treatment amount can be easily increased by increasing the diameter and thickness of the porous material in the production method of the present invention, and the retention rate of the lipophilic substance contained therein is also increased.
【0020】実施例6 23mg/mlのジパルミトイルフォスファチジルコリ
ン(DPPC)、3.8mg/mlのジパルミトイルフ
ォスファチジルセリン(DPPS)、2mg/mlのコ
レステロール、および親油性のサンプルとして色素であ
るスダンIIIを1.7mg/mlを含有するクロロホ
ルム溶液5mlを直径30mm、厚さ3mmのセラミッ
ク焼結体(孔径10〜50μm)を装着した濾過装置に
供給し、膜構成脂質を多孔性材質に付着させた。以下、
実施例1に準じてリポソーム分散液を得た。リポソーム
の径は、平均0.8μm、粒度分布は28%であった。
また、得られたリポソームの水溶液をゲル濾過、凍結乾
燥した。その0.1gをキシレン20mlに溶解し、分
光光度計により標準液と比較してスダンIIIの保持率
を測定したところほぼ100%であった。この結果、本
発明の製造法において多孔性材質にセラミックを用いれ
ば、内包させる親油性物質の保持率が高められ、また、
粒径を小さく均一にすることができることが判明した。Example 6 23 mg / ml dipalmitoylphosphatidylcholine (DPPC), 3.8 mg / ml dipalmitoylphosphatidylserine (DPPS), 2 mg / ml cholesterol, and dye as lipophilic sample 5 ml of a chloroform solution containing 1.7 mg / ml of Sudan III was supplied to a filtration device equipped with a ceramic sintered body (pore size: 10 to 50 μm) having a diameter of 30 mm and a thickness of 3 mm, and the membrane-constituting lipid was used as a porous material. Attached. Less than,
A liposome dispersion was obtained in the same manner as in Example 1. The average diameter of the liposome was 0.8 μm, and the particle size distribution was 28%.
Further, the obtained liposome aqueous solution was subjected to gel filtration and freeze-dried. 0.1 g of the solution was dissolved in 20 ml of xylene, and the retention rate of Sudan III was measured by a spectrophotometer as compared with the standard solution. As a result, if ceramic is used as the porous material in the production method of the present invention, the retention rate of the lipophilic substance to be encapsulated is increased, and
It was found that the particle size can be made small and uniform.
【0021】実施例7 濾過装置に装着した直径30mm、厚さ3mmの多孔性
材質が鉄の焼結体(孔径30〜200μm)を用いた他
は、実施例2に準じてリポソーム分散液を作成した。リ
ポソームの径は、平均5.0μm、粒度分布は35%で
あった。また、得られたリポソームの分散液をゲル濾
過、凍結乾燥し、実施例2に準じてスダンの保持率を測
定したところ91%であった。Example 7 A liposome dispersion liquid was prepared in the same manner as in Example 2 except that a sintered body (pore diameter 30 to 200 μm) of iron having a diameter of 30 mm and a thickness of 3 mm and equipped with a filtration device was used. did. The average diameter of the liposome was 5.0 μm, and the particle size distribution was 35%. The dispersion liquid of the obtained liposomes was subjected to gel filtration and freeze-drying, and the Sudan retention rate was measured according to Example 2 to find that it was 91%.
【0022】比較例1 卵黄レシチン20mgのコレステロール3.8mgを5
0mlのナス型フラスコに入れ、2mlのクロロホルム
を加えて溶解させた。次いで、クロロホルムをロータリ
ーエバポレーターを用いて減圧除去し、これに1mlの
生理食塩水を加え、フラスコを30分振盪して、フラス
コ内壁に付着したフィルムを剥離、分散させた後、生成
した分散液を超音波処理器(日本精機製、NS200−
2型)で20分間処理した。これに6mlの生理食塩水
を加えて、リポソーム分散液を得た。得られたリポソー
ムの粒径は平均3.5μm、粒度分布は45%であっ
た。このように、従来の方法では、ナス型フラスコの表
面積によって、処理量が決定されるので処理量が非常に
少なく、また広い面積に作成された膜から剥離してリポ
ソームを得るため粒度分布の巾が大きく、均一なものが
大量に得られない。Comparative Example 1 Egg yolk lecithin 20 mg cholesterol 3.8 mg 5
The mixture was placed in a 0 ml eggplant-shaped flask, and 2 ml of chloroform was added and dissolved. Then, chloroform was removed under reduced pressure using a rotary evaporator, 1 ml of physiological saline was added thereto, and the flask was shaken for 30 minutes to peel off and disperse the film adhering to the inner wall of the flask, and then to form the dispersion liquid. Ultrasonic processor (Nippon Seiki, NS200-
Type 2) for 20 minutes. To this, 6 ml of physiological saline was added to obtain a liposome dispersion liquid. The average particle size of the obtained liposomes was 3.5 μm, and the particle size distribution was 45%. As described above, in the conventional method, the treatment amount is very small because the surface area of the eggplant-shaped flask determines the treatment amount, and the width of the particle size distribution is large because the liposome is peeled off from the membrane prepared in a large area. Is large, and a large amount of uniform products cannot be obtained.
Claims (1)
いで多孔性材質の表面と水溶液とを接触させるリポソー
ムの製造方法。1. A method for producing liposomes, wherein a membrane-constituting lipid is attached to a porous material and then the surface of the porous material is contacted with an aqueous solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6094593A JP3399009B2 (en) | 1993-02-25 | 1993-02-25 | Method for producing liposome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6094593A JP3399009B2 (en) | 1993-02-25 | 1993-02-25 | Method for producing liposome |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06246150A true JPH06246150A (en) | 1994-09-06 |
JP3399009B2 JP3399009B2 (en) | 2003-04-21 |
Family
ID=13157040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6094593A Expired - Fee Related JP3399009B2 (en) | 1993-02-25 | 1993-02-25 | Method for producing liposome |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3399009B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4887436A (en) * | 1987-11-18 | 1989-12-19 | Mitsubishi Denki Kabushiki Kaisha | Defrosting system for a heat exchanger |
US5702722A (en) * | 1994-09-30 | 1997-12-30 | Bracco Research S.A. | Liposomes with enhanced entrapment capacity, method and use |
US6217899B1 (en) * | 1995-08-15 | 2001-04-17 | Hassan Benameur | Liposomes preparation method and plant |
JP2007268350A (en) * | 2006-03-30 | 2007-10-18 | Toshiba Corp | Apparatus for producing fine particle, emulsifier holding part, method for producing fine particle and method for producing molecular film |
-
1993
- 1993-02-25 JP JP6094593A patent/JP3399009B2/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4887436A (en) * | 1987-11-18 | 1989-12-19 | Mitsubishi Denki Kabushiki Kaisha | Defrosting system for a heat exchanger |
US5702722A (en) * | 1994-09-30 | 1997-12-30 | Bracco Research S.A. | Liposomes with enhanced entrapment capacity, method and use |
US5895661A (en) * | 1994-09-30 | 1999-04-20 | Bracco Research S.A. | Liposome vesicle precursors |
US5980937A (en) * | 1994-09-30 | 1999-11-09 | Bracco Research S.A. | Liposomes with enhanced entrapment capacity and their use in imaging |
US6217899B1 (en) * | 1995-08-15 | 2001-04-17 | Hassan Benameur | Liposomes preparation method and plant |
JP2007268350A (en) * | 2006-03-30 | 2007-10-18 | Toshiba Corp | Apparatus for producing fine particle, emulsifier holding part, method for producing fine particle and method for producing molecular film |
US8066918B2 (en) | 2006-03-30 | 2011-11-29 | Kabushiki Kaisha Toshiba | Apparatus for producing particles, emulsifier holding member, method for producing particles, and method for producing molecular membrane |
Also Published As
Publication number | Publication date |
---|---|
JP3399009B2 (en) | 2003-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zumbuehl et al. | Liposomes of controllable size in the range of 40 to 180 nm by defined dialysis of lipid/detergent mixed micelles | |
US5043164A (en) | Blood-stable, cholesterol-free liposomes | |
US4089801A (en) | Process for the preparation of liposomes | |
US5616334A (en) | Low toxicity drug-lipid systems | |
JP3026271B2 (en) | Preparation of multivesicular liposomes for controlled release of active drug | |
KR100216138B1 (en) | Stable microbubble suspensions as enhancement agents for ultrasound echography | |
JPH0639274A (en) | Method for stabilizing liposome suspension | |
WO1990014074A1 (en) | Improved liposomal formulations of nucleotides and nucleotide analogues | |
JPS59134712A (en) | Manufacture of multi-thin layer lipid cell | |
JPS6339810A (en) | Production of liposome | |
JPH0428412B2 (en) | ||
NZ203299A (en) | Process for the preparation of unilamellar liposomes in aqueous phase and their use as drug delivery systems by encapsulation | |
JPH0753661B2 (en) | Pro-liposome composition and method of making an aqueous dispersion of liposomes | |
EP2368627A1 (en) | Method for producing liposome and method for dissolving cholesterol | |
IE67152B1 (en) | Low toxicity drug-lipid systems | |
US5173219A (en) | Uniform spherical multilamellar liposomes of defined and adjustable size distribution | |
JP5126874B2 (en) | Method for producing liposome preparation | |
KR960014869B1 (en) | Method for preparing a dispersible colloidal system of amphoteric lipids in the form of submicron liposomes | |
JP3399009B2 (en) | Method for producing liposome | |
KR890007719A (en) | Method of preparing liposome population of uniform size | |
JPH08151334A (en) | Liposome and preparation thereof | |
CA2285985C (en) | A method for preparing aqueous liposomal compositions comprising an active ingredient which is highly insoluble in water | |
JPS607933A (en) | Preparation of liposome | |
CA2024804A1 (en) | Prostaglandin-containing liposome preparations | |
JP2003513901A (en) | Method for encapsulating protein or peptide in liposome, liposome prepared by this method and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 5 Free format text: PAYMENT UNTIL: 20080221 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080221 Year of fee payment: 5 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20090221 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 7 Free format text: PAYMENT UNTIL: 20100221 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100221 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110221 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110221 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120221 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20130221 |
|
LAPS | Cancellation because of no payment of annual fees |